Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-04-24

FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)

View source ↗

Summary

FDA approved a supplemental application for DELFLEX, a dextrose-based dialysis solution from Fresenius Medical Care de Mexico, S.A. de C.V., indicating an updat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DELFLEX (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE)

Snippet

SUPPL AP for DELFLEX (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE)